Applied Genetic Technologies reported $43K in Ordinary Share Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Alimera Sciences ALIM:US $ 0.07M 0.01M
Applied Genetic Technologies AGTC:US $ 0.04M 0M
Avrobio Inc AVRO:US $ 4K 0
Biogen BIIB:US $ 0.1M 0M
Bluebird Bio BLUE:US $ 0.68M 0M
Celldex Therapeutics CLDX:US $ 0.04M 0M
Cti Biopharma CTIC:US $ 0.09M 0.02M
Insmed INSM:US $ 1.15M 119K
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M